October 16, 2025

New Criteria, New Numbers on Obesity

A Lancet Commission definition integrating BMI with anthropometric measures increased obesity prevalence by ~60% in a major US cohort, identifying previously unrecognized high-risk patients while introducing distinct clinical phenotypes.

Conexiant

October 16, 2025

Cardiac Rehab Participation One-Third Lower in Women

Women remain underrepresented in cardiac rehabilitation across all stages of participation.

Conexiant

October 15, 2025

Study Describes Patterns in Reported Drug Interactions

Researchers analyze about 177,000 drug interactions to identify key medication safety trends.

Conexiant

October 15, 2025

How Hiring One Optometrist Unlocked £60k a Month in Stalled Revenue

Diagnosing the real bottleneck turned a hiring decision into a £60k/month growth lever

The Ophthalmologist

October 10, 2025

FDA Broadens Label for Schizophrenia Drug

The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder.

Conexiant

October 09, 2025

Is Postoperative AF Changing Anticoagulation Decisions?

Cohort of 198 coronary artery bypass grafting patients monitored for 1 year with insertable cardiac devices found high incidence of new-onset atrial fibrillation but minimal late burden.

Conexiant

October 07, 2025

EASO Issues Obesity Pharmacotherapy Guidance

EASO framework guides obesity drug selection by weight loss effect and complication focus.

Conexiant

October 06, 2025

Evidence-Based Medicine Requires Urgent Reform, Physician Says

Systemic biases and industry influence have undermined the movement's foundational principles, potentially compromising patient care across multiple specialties.

Conexiant

October 03, 2025

Impact of Proton and Photon Therapies on HRQOL in Breast Cancer

Health-related quality-of-life measurements demonstrated that both proton and photon radiation therapy led to excellent and similar impacts on quality of life for patients with breast cancer undergoin...

The ASCO Post